Thus, replenishing NAD + seems to slow down the aging process
Clinical trials show significant weight loss: ~1215% in diabetes patients (Mounjaro) and ~1521% in obesity patients (Zepbound), depending on duration
Whats Actually Happening In Your Stomach About one in eight adults in the US now takes a GLP-1 medication, according to the American Society of Anesthesiologists, which is part of why this conversation has become routine pre-op intake rather than a rare exception
This once-weekly dosing, supported by its approximately 5-day half-life, directly influences injection pen design requirements, demanding devices capable of precise multi-dose or large single-dose delivery
Retatrutide in Type 2 Diabetes Recent clinical research on retatrutide, a novel triple-hormone receptor agonist, has shown promising results for people with type 2 diabetes
If you are exploring the broader category of GLP-1 peptides and want to understand where these two fit within the class, that context matters for dosing decisions